Cargando…

Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009

In children with acute lymphoblastic leukemia (ALL), risk groups for invasive fungal disease (IFD) with need for antifungal prophylaxis are not well characterized, and with the advent of new antifungal compounds, current data on outcome are scarce. Prospectively captured serious adverse event report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehrnbecher, Thomas, Groll, Andreas H., Cesaro, Simone, Alten, Julia, Attarbaschi, Andishe, Barbaric, Draga, Bodmer, Nicole, Conter, Valentino, Izraeli, Shai, Mann, Georg, Möricke, Anja, Niggli, Felix, Schrappe, Martin, Stary, Jan, Zapotocka, Ester, Zimmermann, Martin, Elitzur, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883161/ https://www.ncbi.nlm.nih.gov/pubmed/36509893 http://dx.doi.org/10.1038/s41375-022-01768-x

Ejemplares similares

Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
por: Rizzari, Carmelo, et al.
Publicado: (2023)

Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
por: Heilmann, Janina, et al.
Publicado: (2023)

Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia
por: Schieck, Maximilian, et al.
Publicado: (2020)

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
por: Rizzari, Carmelo, et al.
Publicado: (2019)

Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction
por: Möricke, Anja, et al.
Publicado: (2023)

Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group
por: Junk, Stefanie V., et al.
Publicado: (2023)

Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
por: Cario, Gunnar, et al.
Publicado: (2020)

Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP‐BFM acute lymphoblastic leukemia protocol
por: Jung, Mareike, et al.
Publicado: (2020)

Outcome of ALL With ALL-BFM-95 Protocol in Nepal
por: Sharma Poudyal, Bishesh, et al.
Publicado: (2023)

Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia—A population‐based analysis of the Austrian ALL‐BFM Study Group
por: Poyer, Fiona, et al.
Publicado: (2022)

Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
por: Knörr, Fabian, et al.
Publicado: (2021)

Opportunities and challenges of personalized therapy of patients with HR ALL
por: Izraeli, Shai
Publicado: (2019)

Methotrexate-associated toxicity in children with Down syndrome and acute lymphoblastic leukemia during consolidation therapy with high dose methotrexate according to ALL-BFM treatment regimen
por: Kroll, Mirko, et al.
Publicado: (2020)

Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
por: HAYATI, Hadi, et al.
Publicado: (2018)

PB1747: OUTCOME OF CHILDHOOD ALLTREATED WITH ALL BFM IC 2009 PROTOCOL
por: Çilsaat, Gizem, et al.
Publicado: (2023)

The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL–BFM 2000 protocol can be separated from FBXW7 loss of function
por: Kox, C, et al.
Publicado: (2010)

Incidence and Outcome of Invasive Fungal Diseases in Children With Hematological Malignancies and/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study
por: Lehrnbecher, Thomas, et al.
Publicado: (2019)

Long‐term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC‐BFM 2002 trial
por: Kowalczyk, Jerzy R., et al.
Publicado: (2019)

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
por: Khalil, Alaeddin, et al.
Publicado: (2020)

The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
por: Dalle, Jean-Hugues, et al.
Publicado: (2020)

PAX5-AUTS2: A recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia
por: Denk, Dagmar, et al.
Publicado: (2012)

Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group
por: Rasche, Mareike, et al.
Publicado: (2021)

Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
por: Rasche, Mareike, et al.
Publicado: (2021)

Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland
por: Scheler, Max, et al.
Publicado: (2020)

Second malignancies after treatment of childhood non-Hodgkin lymphoma – a report of the Berlin-Frankfurt-Muenster study group
por: Moser, Olga, et al.
Publicado: (2020)

Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004
por: Bochennek, K, et al.
Publicado: (2016)

Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy
por: Stanulla, Martin, et al.
Publicado: (2001)

P374: THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009-2017)
por: Mattera, Raffaele, et al.
Publicado: (2023)

Sekundärmalignome nach Ganzkörperbestrahlung pädiatrischer Leukämiepatienten – eine kritische Re-Evaluation der multizentrischen ALL-SCT-BFM-2003-Studie
por: Knaack, Christian, et al.
Publicado: (2023)

Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012
por: Rasche, Mareike, et al.
Publicado: (2018)

Use of music therapy in pediatric oncology: an Italian AIEOP multicentric survey study in the era of COVID-19
por: Giordano, Filippo, et al.
Publicado: (2022)

Go with the Flow—Early Assessment of Measurable Residual Disease in Children with Acute Lymphoblastic Leukemia Treated According to ALL IC-BFM2009
por: Pawinska-Wasikowska, Katarzyna, et al.
Publicado: (2022)

Galactomannan and PCR in the Central Nervous System to Detect Invasive Mold Disease - A Retrospective Analysis in Immunocompromised Children
por: Lehrnbecher, Thomas, et al.
Publicado: (2019)

Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP)
por: Parasole, Rosanna, et al.
Publicado: (2018)

Invasive Mold Infection of the Central Nervous System in Immunocompromised Children
por: Porto, Luciana, et al.
Publicado: (2020)

The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols
por: Ampatzidou, Mirella, et al.
Publicado: (2023)

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004
por: Rasche, M, et al.
Publicado: (2017)

“CHildren with Inherited Platelet disorders Surveillance” (CHIPS) retrospective and prospective observational cohort study by Italian Association of Pediatric Hematology and Oncology (AIEOP)
por: Lassandro, Giuseppe, et al.
Publicado: (2022)

School and kindergarten attendance and home schooling of pediatric cancer patients before and during the SARS-CoV-2 pandemic: results of a survey of the German Society for Pediatric Oncology and Hematology
por: Simon, Arne, et al.
Publicado: (2021)

Antimicrobial Use in Pediatric Oncology and Hematology: Protocol for a Multicenter Point-Prevalence Study With Qualitative Expert Panel Assessment
por: Papan, Cihan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tcvrkjeqb24ol3flit7f0t0fe5